Jose Shyam Sushama, Bendickova Kamila, Fric Jan
Cellular and Molecular Immunoregulation Group (CMI), Center for Translational Medicine (CTM), International Clinical Research Center (ICRC), St. Anne's University Hospital Brno, Brno, Czech Republic.
Methods Mol Biol. 2018;1771:121-130. doi: 10.1007/978-1-4939-7792-5_10.
The successful development and characterization of human induced pluripotent stem cells (iPSCs) provides a powerful tool to study the molecular mechanisms that control cell fate decisions and differentiation toward distinct lineages. Here we focus on the ability of donors derived iPSCs to differentiate toward hematopoietic progenitor cells and on the analysis of their telomere length. The ability to screen telomere length in individual donors is important for defining cellular senescence, which correlates with their differentiation potential toward hematopoietic lineages. We have modified iPSC culture protocol and telomere length analysis to suit for high throughput screening of telomere length in large number of individual donors. This approach can be used to demonstrate the heterogeneity or changes of telomere length and its shortening as an exclusion criterion for selection of suitable donors for future stem cell therapies.
人类诱导多能干细胞(iPSC)的成功开发与特性鉴定为研究控制细胞命运决定以及向不同谱系分化的分子机制提供了一个强大工具。在此,我们聚焦于供体来源的iPSC向造血祖细胞分化的能力以及对其端粒长度的分析。在个体供体中筛选端粒长度的能力对于定义细胞衰老很重要,而细胞衰老与它们向造血谱系的分化潜能相关。我们已修改iPSC培养方案和端粒长度分析方法,以适用于对大量个体供体进行端粒长度的高通量筛选。这种方法可用于证明端粒长度的异质性或变化以及其缩短情况,将其作为为未来干细胞治疗选择合适供体的排除标准。